12.30.07
Posted in Uncategorized at 7:48 pm by American Cancer Society :: News and Features
The newest addition to ACS's family of
Facts and Figures reports calculates cancer's toll around the globe.
Permalink
Posted in Uncategorized at 7:48 pm by American Cancer Society :: News and Features
An article in the January issue of
CA: A Cancer Journal for Clinicians explores the impact health insurance status has on cancer screening, diagnosis, and survival rates.
Permalink
Posted in Uncategorized at 7:48 pm by American Cancer Society :: News and Features
A new study suggests many men may be unwittingly choosing prostate cancer treatments that worsen problems they already have.
Permalink
Posted in Uncategorized at 1:00 am by Cancer / Oncology News From Medical News Today
Researchers at the Ireland Cancer Center of University Hospitals Case Medical Center are the first in the region to have joined a nationwide clinical trial to evaluate the effectiveness of a gene therapy in patients with advanced melanoma which is aimed to help a patient's own immune system fight their cancer. The gene therapy is termed Allovectin-7?, and is injected directly into the cancer while it is still in the body in order to make it appear foreign to the immune system. [click link for full article]
Permalink
12.29.07
Posted in Uncategorized at 2:00 am by Cancer / Oncology News From Medical News Today
Hayley McDaid, Ph.D. assistant professor of medicine and of molecular pharmacology at Albert Einstein College of Medicine of Yeshiva University, has received a $100,000 grant from Joan’s Legacy: The Joan Scarangello Foundation to Conquer Lung Cancer for her research of lung cancer. The grant, which is being funded equally over two years by Joan’s Legacy and the LUNGevity Foundation, will support Dr. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Cancer / Oncology News From Medical News Today
Most people wouldn't consider anthrax toxin to be beneficial, but this bacterial poison may someday be an effective cancer therapy. Anthrax toxin has actually been shown to be fairly selective in targeting melanoma cells, although the risk of non-cancer toxicity prevents any clinical use. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Breast Cancer News From Medical News Today
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy. The study, published in the December 27th issue of the New England Journal of Medicine, found that Avastin in combination with chemotherapy significantly prolongs progression-free survival for women with breast cancer compared to chemotherapy alone. [click link for full article]
Permalink
12.28.07
Posted in Uncategorized at 2:00 am by Breast Cancer News From Medical News Today
Cone-beam breast CT provides exceptional tissue contrast and can potentially reduce examination time with comparable radiation dose to conventional 2D mammography, according to a new study by a team of researchers from the University of Texas M. D. Anderson Cancer Center in Houston. Cone-beam breast CT employs a large area x-ray beam in conjunction with a flat panel x-ray detector to scan and generate 3D images of the breast. [click link for full article]
Permalink
Posted in Uncategorized at 2:00 am by Breast Cancer News From Medical News Today
The positive results of the first nationwide clinical study showing the benefits of an antiangiogenic agent in breast cancer therapy are reported in the Dec. 27 issue of the New England Journal of Medicine. The study with Avastin showed the biggest improvement in metastatic breast cancer ever reported in a chemotherapy-based clinical trial. [click link for full article]
Permalink
12.27.07
Posted in Uncategorized at 2:00 am by Breast Cancer News From Medical News Today
Researchers developed a new method for distinguishing between breast cancer recurrences and new primary tumors. One commonly used method is to detect changes in DNA copy number. Another is to compare clinical and pathologic characteristics of the two tumors. Marc Bollet, M.D. [click link for full article]
Permalink
« Previous entries
